8-K: Sabra Health Care REIT Reports Q4 2023 Results and Introduces 2024 Guidance

Sabra Health Care REIT announced its fourth quarter 2023 results, showing improvements in occupancy and rent coverage, and introduced its 2024 earnings guidance.

Summary

• Sabra Health Care REIT reported a net income of $0.07 per diluted share for the fourth quarter of 2023.
• The company's FFO was $0.30 per diluted share, with normalized FFO at $0.32 per diluted share.
• AFFO and normalized AFFO were both $0.32 and $0.33 per diluted share, respectively.
• EBITDARM coverage for skilled nursing/transitional care was 1.78x, senior housing-leased was 1.28x, behavioral health was 1.85x, and specialty hospitals & other was 7.00x.
• Sabra expanded its relationship with Ignite Medical Resorts by acquiring two skilled nursing facilities for $38.8 million with a 9.5% cash lease yield.
• A quarterly cash dividend of $0.30 per share was declared on February 1, 2024, payable on February 29, 2024.
• The company introduced 2024 earnings guidance, projecting net income between $0.53 and $0.57 per diluted share.
• 2024 FFO is projected to be between $1.33 and $1.37 per diluted share, with normalized FFO between $1.34 and $1.38 per diluted share.
• AFFO is expected to be between $1.38 and $1.42 per diluted share, and normalized AFFO between $1.39 and $1.43 per diluted share.
• The 2024 guidance assumes no acquisition or disposition activity.
• Achieving the midpoint of the Normalized FFO and Normalized AFFO guidance would represent a year-over-year increase of 5% and 6%, respectively.
• As of December 31, 2023, Sabra had approximately $946.9 million of liquidity, including $41.3 million in unrestricted cash and $905.6 million available under its revolving credit facility.
• The company also had $500 million available under its ATM program.
• Sabra's investment portfolio included 378 real estate properties with 37,834 beds/units as of December 31, 2023.

Sentiment

Score: 7

Explanation: The document presents a positive outlook with improved financial metrics and forward guidance, but also acknowledges existing risks and challenges. The sentiment is cautiously optimistic.

Positives

• Occupancy and rent coverage continued to improve in skilled nursing and senior housing platforms.
• The company expanded its relationship with Ignite Medical Resorts, a successful operator.
• Sabra introduced full-year guidance for the first time since the pandemic, indicating a return to earnings growth.
• The company has a strong liquidity position with $946.9 million available.
• The company has a diverse portfolio of 378 properties across the United States and Canada.

Negatives

• The company experienced a net loss of $84.9 million in the same quarter of the previous year.
• The company's net income for the year was $13.7 million, down from a loss of $77.6 million in the previous year.
• The company's rental and related revenues decreased from $103.3 million to $93.0 million in the quarter.
• The company's total revenues decreased from $164.9 million to $163.3 million in the quarter.

Risks

• Increased labor costs and historically low unemployment could impact operations.
• Increases in market interest rates and inflation may affect financial performance.
• Pandemics or epidemics, including COVID-19, could impact tenants and communities.
• Operational risks with respect to Senior Housing Managed communities could affect results.
• Competitive conditions in the industry may impact performance.
• The loss of key management personnel could pose a risk.
• Uninsured or underinsured losses affecting properties could impact the company.
• Potential impairment charges and adjustments related to the accounting of assets could affect results.
• The variability of reported rental and related revenues due to accounting standards could impact results.
• Risks associated with investments in unconsolidated joint ventures could affect performance.
• Catastrophic weather and other natural or man-made disasters could impact properties.
• Increased operating costs and competition for tenants could affect performance.
• Increased healthcare regulation and enforcement could impact operations.
• Tenants' dependency on reimbursement from governmental and third-party payor programs could pose a risk.
• The effect of tenants declaring bankruptcy or becoming insolvent could impact the company.
• The ability to find replacement tenants and the impact of unforeseen costs in acquiring new properties could affect results.
• The impact of litigation and rising insurance costs on the business of tenants could pose a risk.
• The impact of required regulatory approvals of transfers of healthcare properties could affect operations.
• Environmental compliance costs and liabilities associated with real estate properties could impact the company.
• Tenants' failure to adhere to privacy and data security laws could pose a risk.
• The company's concentration in the healthcare property sector makes it vulnerable to downturns in specific sectors.
• The significant amount of indebtedness and the ability to service it could pose a risk.
• Covenants in debt agreements may restrict the ability to pay dividends, make investments, incur additional indebtedness, and refinance debt.
• Adverse changes in credit ratings could impact the company.
• The ability to make dividend distributions at expected levels could be affected.
• The ability to raise capital through equity and debt financings could be impacted.
• Changes and uncertainty in macroeconomic conditions and disruptions in the financial markets could affect performance.
• Risks associated with ownership of property outside the U.S., including currency fluctuations, could impact results.
• The relatively illiquid nature of real estate investments could pose a risk.
• The ability to maintain REIT status under federal tax laws could be affected.
• Compliance with REIT requirements and certain tax and tax regulatory matters could impact the company.
• Changes in tax laws and regulations affecting REITs could affect performance.
• Ownership limits and takeover defenses in governing documents and under Maryland law may restrict change of control or business combination opportunities.
• Exclusive forum provisions in bylaws could pose a risk.

Future Outlook

Sabra introduced 2024 earnings guidance, projecting net income between $0.53 and $0.57 per diluted share, FFO between $1.33 and $1.37 per diluted share, normalized FFO between $1.34 and $1.38 per diluted share, AFFO between $1.38 and $1.42 per diluted share, and normalized AFFO between $1.39 and $1.43 per diluted share. The guidance assumes no acquisition or disposition activity.

Management Comments

• Rick Matros, CEO and Chair, said, 'We are pleased with the continued progress toward stability and growth that we experienced in the fourth quarter of 2023.'
• Rick Matros also stated, 'For the first time since the pandemic, Sabra has introduced full-year guidance as we look forward to a return to earnings growth.'
• Talya Nevo-Hacohen, Chief Investment Officer, stated, 'By consistently and deliberately executing our strategy, we deliver long-term value to our shareholders and provide the capital our tenants need to invest in their business and deliver quality care.'

Industry Context

This announcement reflects a positive trend in the healthcare REIT sector, with improvements in occupancy and rent coverage indicating a recovery from the pandemic's impact. The introduction of full-year guidance suggests confidence in future performance, aligning with broader industry expectations for stabilization and growth.

Comparison to Industry Standards

• Sabra's EBITDARM coverage for skilled nursing facilities at 1.78x is within the range of its peers, but slightly lower than some of the higher performing companies such as LTC and NHI.
• The company's senior housing EBITDARM coverage at 1.28x is also within the range of its peers, but lower than some of the more diversified REITs like WELL and VTR.
• Sabra's leverage at 5.74x Net Debt to Adjusted EBITDA is within the range of its investment grade peers, but higher than some of the more conservative REITs.
• The company's secured debt as a percentage of asset value at 1% is very low compared to some peers, indicating a strong balance sheet.
• Sabra's forward FFO multiple of 13.2x is within the range of its peers, but lower than some of the higher growth REITs.
• The company's dividend yield of 8.7% is higher than most of its peers, making it attractive to income-seeking investors.

Stakeholder Impact

• Shareholders will benefit from the declared dividend and the projected earnings growth.
• Employees will benefit from the company's commitment to diversity, equity, and inclusion.
• Tenants will benefit from the company's support for their expansion and growth.
• Customers (residents and patients) will benefit from the company's focus on quality care.
• Creditors will benefit from the company's strong balance sheet and liquidity position.

Next Steps

• The company will hold a conference call on February 28, 2024, to discuss the fourth quarter results.
• The company will continue to execute its strategy to deliver long-term value to shareholders.
• The company will focus on maintaining balance sheet strength and prioritizing available liquidity.

Key Dates

Keywords

Healthcare REIT, Skilled Nursing, Senior Housing, Behavioral Health, Real Estate Investment, EBITDARM, FFO, AFFO, Dividend, Liquidity, Occupancy, REIT, Net Income, Financial Guidance